Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTEIN: Amino Acid Therapy for AKI Prevention in Pediatric Heart Surgery
NCT07880951Phase 2Not yet recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Oct 2027
- Primary completion
- Oct 2032
01
Overview
Phase 2, randomised, double-blind trial of trophamine in acute kidney injury (AKI) (2 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Persistent Acute Kidney Injury and Urine NGAL, KIM-1 and L-FABP levels. Planned start Oct 2027; status: not yet recruiting.
02
Drugs
trophamine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07880951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880951.